BioSpace News Archive

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors.

Hematology involves the study of blood, in particular how blood can affect overall health. Used in different settings, hematology instruments can do blood count, detect proteins or enzymes, and help to diagnose illnesses or genetic defects.

Dehydration monitoring systems are a group of healthcare or medical devices, notably wearable, used in physiological monitoring of presence of water in human bodies.

The global critical care information systems market is all set to depict upward curve of growth during the forecast period of 2019 to 2027.

The global counterfeit drug detection device market is all set to show upward graph of revenues during the forecast period of 2019 to 2027.

The global aromatherapy market is pegged to capture handsome amount in the form of revenues during the forecast period of 2019 to 2029.

Vertex Pharmaceuticals Incorporated and Arbor Biotechnologies announced a new collaboration to enhance efforts in developing ex vivo engineered cell therapies, using Arbor’s proprietary CRISPR gene-editing technology for select diseases.

Global WholeHealth Partners Corp. (OTC: GWHP) is readying for sales due to the transition from Emergency Use Status to Full FDA Approval of Vaccine developed by Pfizer-BioNTech, as stated in 8K filing 06/15/21.

Regeneron Pharmaceuticals, Inc. announced that an ongoing Phase 2 proof-of-concept trial evaluating an investigational 8 mg dose of aflibercept met its primary safety endpoint, with no new safety signals observed compared to the currently-approved 2 mg dose of EYLEA® Injection in patients with wet age-related macular degeneration.

Castle Biosciences, Inc. today announced that it has been awarded a five-year U.S. Federal Supply Schedule (FSS) contract from the Veterans Health Administration (VHA) for its DecisionDx®-Melanoma gene expression profile test.